A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients

Cancer

Volumn 116, Issue 11, 2010, Pages 2543-2548

  Bedrosian, Isabelle ^a   Babiera, Gildy V ^a   Mittendorf, Elizabeth A ^a   Kuerer, Henry M ^a   Pantoja, Laura ^a   Hunt, Kelly K ^a   Krishnamurthy, Savitri ^a   Meric Bernstam, Funda ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Axilla; Breast cancer; Clinical trial; Lymph node dissection; Lymphedema; Phase 1

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; ISOSULFAN BLUE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; AXILLARY REVERSE MAPPING; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM EXAMINATION; PATIENT SAFETY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; LYMPHEDEMA; MIDDLE AGED;

EID: 77951294464     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25096     Document Type: Article

References (13)

1. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-553.
2. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med. 1998;339:941-946. (Pubitemid 28455095)
3. Petrek JA, Senie RT, Peters M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368-1377. (Pubitemid 32947819)
4. Norman SA, Localio AR, Potashnik SL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390-397.
5. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26:5213-5219.
6. Thompson M, Korourian S, Henry-Tillman R, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007;14:1890-1895. (Pubitemid 46870948)
7. Boneti C, Korourian S, Bland K, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg. 2008;206:1038-1042; discussion 1042-1044.
8. Nos C, Kaufmann G, Clough KB, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol. 2008;15:2550-2555.
9. Raut CP, Hunt KK, Akins JS, et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer. 2005;104:692-699.
10. Kang S-H, Choi J-E, Jeon Y-S, et al. Preservation of lymphatic drainage from arm in breast cancer surgery: is it safe? Presented at the San Antonio Breast Cancer Symposium, San Antonio, Texas, December 10-14, 2008.
11. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25:3657-3663. (Pubitemid 47372604)
12. Suami H, Taylor GI, Pan WR. The lymphatic territories of the upper limb: anatomical study and clinical implications. Plast Reconstr Surg. 2007;119:1813-1822. (Pubitemid 46632068)
13. Boccardo F, Casabona F, De Cian F, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009;16:703-708.